HNSBF
Price
$2.91
Change
-$1.67 (-36.46%)
Updated
Nov 6 closing price
Capitalization
341.73M
Intraday BUY SELL Signals
MLLCF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
154.82M
Intraday BUY SELL Signals
Interact to see
Advertisement

HNSBF vs MLLCF

Header iconHNSBF vs MLLCF Comparison
Open Charts HNSBF vs MLLCFBanner chart's image
Hansa Medical AB
Price$2.91
Change-$1.67 (-36.46%)
Volume$28.75K
Capitalization341.73M
Molecular Partners AG
PriceLoading...
Change-$0.00 (-0.00%)
Volume$2K
Capitalization154.82M
HNSBF vs MLLCF Comparison Chart in %
HNSBF
Daily Signal:
Gain/Loss:
MLLCF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HNSBF vs. MLLCF commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HNSBF is a Hold and MLLCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (HNSBF: $2.91 vs. MLLCF: $3.60)
Brand notoriety: HNSBF and MLLCF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HNSBF: 260% vs. MLLCF: 183%
Market capitalization -- HNSBF: $341.73M vs. MLLCF: $154.82M
HNSBF [@Biotechnology] is valued at $341.73M. MLLCF’s [@Biotechnology] market capitalization is $154.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HNSBF’s FA Score shows that 0 FA rating(s) are green whileMLLCF’s FA Score has 0 green FA rating(s).

  • HNSBF’s FA Score: 0 green, 5 red.
  • MLLCF’s FA Score: 0 green, 5 red.
According to our system of comparison, MLLCF is a better buy in the long-term than HNSBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HNSBF’s TA Score shows that 3 TA indicator(s) are bullish while MLLCF’s TA Score has 4 bullish TA indicator(s).

  • HNSBF’s TA Score: 3 bullish, 2 bearish.
  • MLLCF’s TA Score: 4 bullish, 1 bearish.
According to our system of comparison, MLLCF is a better buy in the short-term than HNSBF.

Price Growth

HNSBF (@Biotechnology) experienced а 0.00% price change this week, while MLLCF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HNSBF($342M) has a higher market cap than MLLCF($155M). HNSBF YTD gains are higher at: -3.000 vs. MLLCF (-12.409). MLLCF has higher annual earnings (EBITDA): -62.52M vs. HNSBF (-506.53M). HNSBF has more cash in the bank: 354M vs. MLLCF (114M). MLLCF has less debt than HNSBF: MLLCF (1.84M) vs HNSBF (906M). HNSBF has higher revenues than MLLCF: HNSBF (196M) vs MLLCF (681K).
HNSBFMLLCFHNSBF / MLLCF
Capitalization342M155M221%
EBITDA-506.53M-62.52M810%
Gain YTD-3.000-12.40924%
P/E RatioN/AN/A-
Revenue196M681K28,781%
Total Cash354M114M311%
Total Debt906M1.84M49,320%
FUNDAMENTALS RATINGS
HNSBF vs MLLCF: Fundamental Ratings
HNSBF
MLLCF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
6576
P/E GROWTH RATING
1..100
10081
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MLLCF's Valuation (45) in the null industry is in the same range as HNSBF (58). This means that MLLCF’s stock grew similarly to HNSBF’s over the last 12 months.

MLLCF's Profit vs Risk Rating (100) in the null industry is in the same range as HNSBF (100). This means that MLLCF’s stock grew similarly to HNSBF’s over the last 12 months.

MLLCF's SMR Rating (97) in the null industry is in the same range as HNSBF (100). This means that MLLCF’s stock grew similarly to HNSBF’s over the last 12 months.

HNSBF's Price Growth Rating (65) in the null industry is in the same range as MLLCF (76). This means that HNSBF’s stock grew similarly to MLLCF’s over the last 12 months.

MLLCF's P/E Growth Rating (81) in the null industry is in the same range as HNSBF (100). This means that MLLCF’s stock grew similarly to HNSBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HNSBFMLLCF
RSI
ODDS (%)
Bullish Trend 7 days ago
29%
Bearish Trend 7 days ago
50%
Stochastic
ODDS (%)
N/A
Bullish Trend 7 days ago
61%
Momentum
ODDS (%)
Bullish Trend 7 days ago
19%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
12%
Bullish Trend 7 days ago
41%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
25%
Bullish Trend 7 days ago
38%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 7 days ago
14%
Bullish Trend 7 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
HNSBF
Daily Signal:
Gain/Loss:
MLLCF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNROF34.81N/A
N/A
Sanrio Co. Ltd.
DBSDY166.70N/A
N/A
DBS Group Holdings Ltd.
GLATF0.37N/A
N/A
Global Atomic Corp.
TBBA6.26N/A
N/A
TEB Bancorp Inc.
HMNTY18.00N/A
N/A
HEMNET GROUP AB

HNSBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HNSBF has been loosely correlated with ENSC. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if HNSBF jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSBF
1D Price
Change %
HNSBF100%
N/A
ENSC - HNSBF
33%
Loosely correlated
-4.57%
CVAC - HNSBF
33%
Poorly correlated
-1.54%
MLLCF - HNSBF
27%
Poorly correlated
N/A
GNPX - HNSBF
25%
Poorly correlated
-4.91%
GRI - HNSBF
25%
Poorly correlated
-1.02%
More

MLLCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLLCF has been loosely correlated with ENSC. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MLLCF jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLLCF
1D Price
Change %
MLLCF100%
N/A
ENSC - MLLCF
37%
Loosely correlated
-4.57%
CYYNF - MLLCF
31%
Poorly correlated
N/A
HNSBF - MLLCF
27%
Poorly correlated
N/A
URGN - MLLCF
26%
Poorly correlated
-14.41%
GNPX - MLLCF
24%
Poorly correlated
-4.91%
More